Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference32 articles.
1. Arterial stiffening and vascular calcifications in end-stage renal disease;Guerin;Nephrol Dial Transplant,2000
2. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis;Goodman;N Engl J Med,2000
3. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality;London;Nephol Dial Transplant,2003
4. Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients;Chertow;Kidney Int,2002
5. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study;Block;Am J Kidney Dis,1998
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sevelamer Improves Vascular Stiffness and Decreases Serum Uric Acid Levels in Patients Ongoing Hemodialysis;Journal of Ankara University Faculty of Medicine;2024-08-13
2. Biochemical markers of iron status and iron accumulation in peritoneal dialysis patients treated with ferric citrate;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2023-09-10
3. Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS;Nephrology Dialysis Transplantation;2020-06-29
4. The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis;Nephrology Dialysis Transplantation;2016-09-20
5. Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder;British Journal of Pharmacology;2016-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3